Skip to main content
. 2011 Sep 29;6:92. doi: 10.1186/1746-1596-6-92

Table 1.

Antibodies used and immunohistchemical result.


Antibody Clone Dilution Source Stroma around the micropapillary clusters Tumor cells
in SMP outside SMP

Case1 Case2 Case1 Case2 Case1 Case2

MUC1 Ma695 1:100 Novocastra 0 0 2+ 2+ 1+ 2+
EMA E29 Pre-diluted Cell Marque 0 0 2+ 2+ 2+ 2+
E-cadherin NCH38D 1:100 DakoCytomation 0 0 2+ 2+ 2+ 2+
CK AE1/AE3 Pre-diluted Nichirei 0 0 2+ 2+ 2+ 2+
TTF-1 8G7G3/1 1:100 DakoCytomation 0 0 1+ 2+ 2+ 2+
SP-A PE10 1:100 Dako 0 0 1+ 0 2+ 2+
D2-40 D2-40 Pre-diluted Nichirei 0 0 0 0 0 0
CD34 Nu-4A1 Pre-diluted Nichirei 0 0 0 0 0 0
FactorVIII polyclonal 1:200 DAKO 0 0 0 0 0 0

EMA, epithelial membrane antigen; CK, cytokeratin; TTF-1, thyroid transcription factor-1; SP-A, surfactant protein A.

Novocastra, Newcastle Upon Tyne, UK; Cell Marque, Hot springs, AR, USA; DakoCytomation, Carpinteria, CA, USA; Dako, Kyoto, Japan; Nichirei, Tokyo, Japan; DAKO, Glostrup, Denmark.

0, no positive cells; 1+, positive tumor cells less than 10%; 2+, 10% or more.